Healthcare Sector
Medical Laboratories Industry 
|
|
|
Data by Company within Medical Laboratories Industry
|
| |
Marketcap |
Revenues (TTM) |
Net Income (TTM) |
Employees |
| Company |
(Millions) |
(Millions) |
(Millions) |
Number |
| Alliance Healthcare Services, Inc |
$ 284 |
$ 524 |
$ 18 |
- |
| Castle Biosciences Inc |
$ 550 |
$ 98 |
$ 17 |
- |
| American Shared Hospital Services |
$ 15 |
$ 19 |
$ 1 |
- |
| Arrowhead Pharmaceuticals Inc |
$ 3,908 |
$ 263 |
$ -112 |
- |
| Biocept Inc |
$ 183 |
$ 78 |
$ 7 |
- |
| Cannlabs, Inc. |
- |
- |
$ 0 |
- |
| Cascadian Therapeutics, Inc. |
$ 508 |
- |
$ -58 |
- |
| Cannabis Science, Inc. |
$ 12 |
$ 0 |
$ -9 |
- |
| Cryo cell International Inc |
$ 55 |
$ 29 |
$ 2 |
- |
| Caredx Inc |
$ 1,371 |
$ 308 |
$ -50 |
- |
| China Health Industries Holdings Inc |
$ 11 |
$ 0 |
$ -1 |
- |
| Nuo Therapeutics, Inc. |
- |
- |
$ 0 |
- |
| Charles River Laboratories International inc |
$ 11,940 |
$ 3,630 |
$ 430 |
- |
| Wod Retail Solutions Inc |
$ 27,659 |
- |
$ 24 |
- |
| Quest Diagnostics Inc |
$ 17,065 |
$ 10,679 |
$ 1,963 |
47,000 |
| Science 37 Holdings Inc |
$ 80 |
- |
$ -1 |
- |
| Dyax Corp |
- |
- |
$ 0 |
- |
| Enzo Biochem Inc |
$ 115 |
$ 118 |
$ 0 |
- |
| Exact Sciences Corporation |
$ 9,274 |
$ 1,850 |
$ -745 |
- |
| Exelixis Inc |
$ 5,742 |
$ 1,521 |
$ 677 |
- |
| First Choice Healthcare Solutions, Inc. |
$ 2 |
$ 87 |
$ -4 |
- |
| Foundation Medicine, Inc. |
$ 5,041 |
$ 179 |
$ -152 |
- |
| Evolutionary Genomics Inc. |
$ 4 |
$ 0 |
$ -4 |
- |
| Genomic Health Inc |
$ 2,443 |
$ 429 |
$ 50 |
- |
| Complete Genomics Inc |
- |
- |
$ 0 |
- |
| Geovax Labs Inc |
$ 10 |
$ 0 |
$ -19 |
- |
| Human Genome Sciences Inc |
- |
- |
$ 0 |
- |
| Icagen, Inc. |
- |
$ 14 |
$ -14 |
- |
| Icon Plc |
$ 14,710 |
$ 5,481 |
$ 153 |
- |
| Incyte Corp |
$ 16,694 |
$ 3,115 |
$ 933 |
1,773 |
| International Stem Cell Corporation |
$ 4 |
$ 8 |
$ 0 |
- |
| Kraig Biocraft Laboratories Inc |
$ 66 |
$ 0 |
$ -8 |
5 |
| Laboratory Corporation Of America Holdings |
$ 23,363 |
$ 15,859 |
$ 2,102 |
65,000 |
| Luna Innovations Inc |
$ 174 |
$ 84 |
$ 11 |
- |
| Medical Imaging Corp. |
$ 0 |
$ 7 |
$ -3 |
- |
| Miragen Therapeutics Inc |
$ 1,221 |
$ 4 |
$ -37 |
- |
| Nanoviricides inc. |
$ 30 |
- |
$ -8 |
- |
| Natera Inc |
$ 3,819 |
$ 667 |
$ -546 |
- |
| Invitae Corporation |
$ 829 |
$ 481 |
$ -451 |
- |
| Nexeon Medsystems Inc |
- |
- |
$ -2 |
- |
| Pressure Biosciences Inc. |
$ 17 |
$ 2 |
$ -19 |
- |
| Pacifichealth Laboratories Inc |
- |
- |
$ 0 |
- |
| Pieris Pharmaceuticals Inc |
$ 133 |
$ 34 |
$ -41 |
- |
| Psychemedics Corp |
$ 25 |
$ 26 |
$ -1 |
- |
| Pra Health Sciences Inc |
$ 10,932 |
$ 3,333 |
$ 213 |
- |
| Parexel International Corp |
$ 4,510 |
$ 2,442 |
$ 107 |
- |
| Prourocare Medical Inc. |
- |
- |
$ 0 |
- |
| Radnet Inc |
$ 1,066 |
$ 1,344 |
$ 39 |
- |
| Response Biomedical Corp |
- |
- |
$ 0 |
- |
| Sunshine Biopharma Inc |
$ 15,609 |
$ 0 |
$ -12 |
- |
| Exagen Inc |
$ 81 |
$ 48 |
$ 2 |
- |
| Senomyx Inc |
$ 72 |
$ 26 |
$ -2 |
- |
| Sorrento Therapeutics Inc |
$ 536 |
$ 57 |
$ -472 |
- |
| Stallion Synergies, Inc |
- |
- |
$ 0 |
- |
| Dr. Tattoff, Inc. |
- |
- |
$ 0 |
- |
| Tenax Therapeutics Inc |
- |
- |
$ -54 |
- |
| Titanium Healthcare, Inc. |
- |
- |
$ 0 |
- |
| United Health Products Inc. |
$ 181 |
$ 0 |
$ -4 |
- |
| Veracyte Inc |
$ 1,308 |
$ 251 |
$ -48 |
- |
| Vitro Diagnostics Inc, |
- |
- |
$ 0 |
- |
| Pluralsight Inc |
$ 2,699 |
$ 392 |
$ -164 |
- |
| Aikido Pharma Inc. |
$ 27 |
- |
$ -4 |
- |
| Malachite Innovations Inc |
$ 12 |
- |
$ 0 |
- |
| Eventbrite Inc |
$ 1,191 |
$ 215 |
$ -72 |
- |
| Dermtech Inc |
$ 200 |
$ 13 |
$ -93 |
- |
| Celcuity Inc. |
$ 85 |
- |
$ -35 |
- |
| Iqvia Holdings Inc |
$ 39,034 |
$ 14,033 |
$ 1,079 |
68,000 |
| National Research Corporation |
$ 827 |
$ 151 |
$ 37 |
- |
| Guardant Health Inc |
$ 3,745 |
$ 391 |
$ -401 |
- |
| Cloudweb Inc |
- |
- |
$ -104 |
- |
| Aurora Mobile Ltd |
- |
$ 56 |
$ -22 |
- |
| Bionexus Gene Lab Corp. |
- |
$ 13 |
$ 0 |
- |
| Syneos Health Inc |
$ 7,404 |
$ 5,340 |
$ 242 |
- |
| Personalis Inc |
$ 199 |
$ 80 |
$ -81 |
- |
| Maxcyte inc |
$ 501 |
$ 12 |
$ -4 |
- |
| Precigen Inc |
$ 248 |
$ 111 |
$ -94 |
- |
| Biodesix Inc |
$ 46 |
$ 32 |
$ -52 |
- |
| Ppd Inc |
$ 16,999 |
- |
$ 0 |
- |
| Yield10 Bioscience inc |
$ 13 |
$ 1 |
$ -12 |
- |
| Burning Rock Biotech Limited |
- |
$ 80 |
$ -125 |
- |
| Inotiv inc. |
$ 464 |
$ 277 |
$ -76 |
- |
| Viridian Therapeutics Inc |
$ 355 |
$ 2 |
$ -87 |
- |
| Genetron Holdings Ltd |
- |
$ 83 |
$ -79 |
- |
| Vyant Bio Inc. |
$ 19 |
$ 1 |
$ -43 |
- |
| Zymergen Inc |
$ 131 |
$ 18 |
$ -349 |
- |
| U s Stem Cell Inc |
- |
$ 0 |
$ -3 |
- |
| Ispecimen inc |
$ 23 |
$ 3 |
$ -2 |
- |
| Opgen Inc |
$ 18 |
$ 4 |
$ -27 |
- |
| Absci Corp |
$ 316 |
$ 1 |
$ -29 |
- |
| Grapefruit Usa Inc. |
$ 11 |
$ 0 |
$ -5 |
- |
| Sera Prognostics Inc |
$ 47 |
$ 0 |
$ -12 |
- |
| Somalogic Inc |
$ 1,050 |
- |
$ -4 |
- |
| Intercure Ltd |
$ 308 |
$ 220 |
$ 7 |
- |
| Medical Laboratories Industry |
$ 257,625 |
$ 74,625 |
$ 3,256 |
181,778 |
| Earnings |
|
Earnings |
|
Earnings |
|
Earnings Outlook increase
Looking into earnings estimates within the Medical Laboratories Industry in the current quarter, 100 % of companies, who provide earning guidance within Medical Laboratories Industry have increased their earnings outlook for the current fiscal year. But this falls short, as more corporations cut their earnings estimates. |
Earnings Guidance unchanged
In the same quarter, none of those companies, who issued earnings outlook, has reiterated its earnings estimates within the Medical Laboratories Industry. |
Earnings Estimates
decrease
There were no decreases in earnings estimates within Medical Laboratories Industry |
|
Expected
Eps Growth |
|
|
Eps
Expectation Revision |
|
 |
% Industry
Expected EPS Growth |
|
Total Ranking # Within Sector # |
|
|
|
% Industry
Earnings Outlook Revision |
|
Total Ranking # Within Sector # |
|
|
|
Revenue |
|
Revenue |
|
Revenue |
Sales Forecast increase
Within Medical Laboratories Industry there were no increases of sales guidance. |
Sales Expectations unchanged
Among companies who provide sales guidance within Medical Laboratories Industry 50 %, have reiterated own sales estimates for the current fiscal year. |
Sales Outlook decrease
On the negative side, 50 % of businesses within Medical Laboratories Industry, that provide top-line expectation, expect now to sell less, compare to the previous guidance. |
|
Expected
Revenue Growth |
|
|
Revenue
Expectation Revision |
|
|
|
% Industry
Expected Revenue Growth |
|
Total Ranking # Within Sector # |
|
|
|
% Industry
Revenue Outlook Revision |
|
Total Ranking # Within Sector # |
|
|
|
